Groningen, Netherlands

Leonard Alexander Van Vliet

This inventor holds 1 USPTO granted patent. Top assignee: Other. Active years: 2001.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Leonard Alexander Van Vliet. Retrieved from https://idiyas.com/inventor/leonard-alexander-van-vliet

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


Average Co-Inventor Count = 6.0

ph-index = 1

Forward Citations = 1(Granted Patents)


Company Filing History:

goldMedal1 out of 834,570 
Other
 patents

Years Active: 2001

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Leonard Alexander Van Vliet: Innovator in Medicinal Chemistry

Introduction

Leonard Alexander Van Vliet is a notable inventor based in Groningen, Netherlands. He has made significant contributions to the field of medicinal chemistry, particularly in the development of compounds that affect the dopaminergic system of the central nervous system.

Latest Patents

Van Vliet holds a patent for "2-aminothiazol-fused 2-aminoindans and 2-aminotetralins and their use." This invention relates to a class of compounds characterized by a general formula that includes various substituents, such as hydrogen atoms and alkyl groups. These compounds are designed for use in pharmaceutical compositions aimed at treating conditions related to the dopaminergic system and circulation.

Career Highlights

Throughout his career, Van Vliet has focused on innovative approaches to drug development. His work has led to advancements in the understanding and application of medicinal compounds, contributing to the broader field of pharmacology.

Collaborations

He has collaborated with notable colleagues, including Durk Dijkstra and Lars Gunne, to further enhance the impact of his research and inventions.

Conclusion

Leonard Alexander Van Vliet's contributions to medicinal chemistry exemplify the importance of innovation in developing new therapeutic agents. His patent reflects a commitment to advancing healthcare through scientific discovery.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…